Neurogene Inc. Annual Operating Income (Loss) in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Neurogene Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2016 to 2023.
  • Neurogene Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$22.2M, a 45.7% decline year-over-year.
  • Neurogene Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$75.8M, a 44.4% decline year-over-year.
  • Neurogene Inc. annual Operating Income (Loss) for 2023 was -$55.6M, a 1.65% increase from 2022.
  • Neurogene Inc. annual Operating Income (Loss) for 2022 was -$56.5M, a 6.89% increase from 2021.
  • Neurogene Inc. annual Operating Income (Loss) for 2021 was -$60.7M, a 80% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$55.6M +$934K +1.65% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-18
2022 -$56.5M +$4.18M +6.89% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 -$60.7M -$27M -80% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-20
2020 -$33.7M +$37.2M +52.5% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 -$71M -$38.3M -118% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-25
2018 -$32.6M +$18.5M +36.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$51.1M -$13.5M -35.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 -$37.6M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.